Dr David W Turner, DC | |
4303 Chicot St, Pascagoula, MS 39581-4701 | |
(228) 762-3935 | |
(228) 762-3935 |
Full Name | Dr David W Turner |
---|---|
Gender | Male |
Speciality | Chiropractic |
Experience | 38 Years |
Location | 4303 Chicot St, Pascagoula, Mississippi |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1831283753 | NPI | - | NPPES |
0114867 | Medicaid | MS |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
111N00000X | Chiropractor | 755 (Mississippi) | Primary |
111N00000X | Chiropractor | 1324 (Alabama) | Secondary |
Provider Name | David W. Turner, D.c., P.a. |
---|---|
Provider Type | Part B Supplier - Clinic/group Practice |
Provider Identifiers | NPI Number: 1366543738 PECOS PAC ID: 4082798772 Enrollment ID: O20080219000498 |
News Archive
A new University of Wisconsin-Madison imaging study shows the brains of people with generalized anxiety disorder (GAD) have weaker connections between a brain structure that controls emotional response and the amygdala, which suggests the brain's "panic button" may stay on due to lack of regulation.
A new Tel Aviv University study finds that eosinophils - white blood cells that may have played an evolutionary role in combating parasites, but which are today responsible for chronic asthma and modern allergies - may be used to eliminate malignant colon cancer cells.
A reduction by half in the radiation dose to which cardiac patients are exposed during diagnostic perfusion imaging is now "feasible", according to an Israeli study.
Researchers from China and the United Kingdom have collaborated to conduct a clinical trial looking at the efficacy of a combination of two anti-HIV drugs lopinavir and ritonavir to combat severe cases of COVID-19. Their study titled, "A Trial of Lopinavir–Ritonavir in Adults Hospitalized with Severe COVID-19," was published in the latest issue of the New England Journal of Medicine (NEJM).
A late-breaking clinical trial, known as the Treatment of Preserved Cardiac Function Heart Failure with an Aldosterone Antagonist trial, to be presented at the American Heart Association Scientific Sessions, November 18, 2013, demonstrates that spironolactone did not reduce the primary outcome of cardiovascular death, heart failure hospitalization, nor surviving a cardiac arrest in patients with heart failure and preserved ejection fraction (pump function). However, spironolactone did reduce the major burden faced by these patients-the risk of repeated hospitalizations for heart failure.
› Verified 7 days ago
Mailing Address | Practice Location Address |
---|---|
Dr David W Turner, DC 4303 Chicot Street, Pascagoula, MS 39581-4701 Ph: (228) 762-3935 | Dr David W Turner, DC 4303 Chicot St, Pascagoula, MS 39581-4701 Ph: (228) 762-3935 |
News Archive
A new University of Wisconsin-Madison imaging study shows the brains of people with generalized anxiety disorder (GAD) have weaker connections between a brain structure that controls emotional response and the amygdala, which suggests the brain's "panic button" may stay on due to lack of regulation.
A new Tel Aviv University study finds that eosinophils - white blood cells that may have played an evolutionary role in combating parasites, but which are today responsible for chronic asthma and modern allergies - may be used to eliminate malignant colon cancer cells.
A reduction by half in the radiation dose to which cardiac patients are exposed during diagnostic perfusion imaging is now "feasible", according to an Israeli study.
Researchers from China and the United Kingdom have collaborated to conduct a clinical trial looking at the efficacy of a combination of two anti-HIV drugs lopinavir and ritonavir to combat severe cases of COVID-19. Their study titled, "A Trial of Lopinavir–Ritonavir in Adults Hospitalized with Severe COVID-19," was published in the latest issue of the New England Journal of Medicine (NEJM).
A late-breaking clinical trial, known as the Treatment of Preserved Cardiac Function Heart Failure with an Aldosterone Antagonist trial, to be presented at the American Heart Association Scientific Sessions, November 18, 2013, demonstrates that spironolactone did not reduce the primary outcome of cardiovascular death, heart failure hospitalization, nor surviving a cardiac arrest in patients with heart failure and preserved ejection fraction (pump function). However, spironolactone did reduce the major burden faced by these patients-the risk of repeated hospitalizations for heart failure.
› Verified 7 days ago
Dr. Johnny Ferdinand Walker Iii, D.C. Chiropractor Medicare: Not Enrolled in Medicare Practice Location: 1112d Ingalls Ave, Pascagoula, MS 39567 Phone: 228-696-1963 Fax: 228-497-1072 | |
Hinman Chiropractic Care, Pa Chiropractor Medicare: Medicare Enrolled Practice Location: 3215 Market Street, Pascagoula, MS 39567 Phone: 228-762-7541 Fax: 228-769-9128 | |
Dr. Munson Paul Hinman, D.C. Chiropractor Medicare: Accepting Medicare Assignments Practice Location: 3215 Market St, Pascagoula, MS 39567 Phone: 228-762-7541 Fax: 228-769-9128 | |
Turner Chiropactic Clinic Chiropractor Medicare: Medicare Enrolled Practice Location: 4303 Chicot St, Pascagoula, MS 39581 Phone: 228-762-3935 | |
Walker Chiropractic Center, Pllc Chiropractor Medicare: Not Enrolled in Medicare Practice Location: 1408 Ingalls Ave, Pascagoula, MS 39567 Phone: 228-696-1963 Fax: 228-696-8845 |